Effectiveness of Brexpiprazole in a Patient With Bipolar Disorder and Comorbid Persistent Genital Arousal Disorder/Genito-Pelvic Dysesthesia: A Case Report

Although the symptoms of persistent genital arousal disorder/genito-pelvic dysesthesia (PGAD/GPD) can have negative impacts on patients' lives, it is an under-recognized clinical entity. We describe the case of a 61-year-old Japanese female who suffered simultaneously from bipolar disorder and...

Full description

Saved in:
Bibliographic Details
Published inCurēus (Palo Alto, CA) Vol. 15; no. 12; p. e50349
Main Authors Hirose, Yuki, Oda, Yasunori, Kobayashi, Tatsuya, Okada, Kazuki, Iyo, Masaomi
Format Journal Article
LanguageEnglish
Published United States Springer Nature B.V 11.12.2023
Cureus
Subjects
Anxiety
Bipolar disorder
Botulinum toxin
Case reports
Clitoris
Cognitive behavioral therapy
Comorbidity
Hospitals
Hypnotherapy
Mental depression
Mindfulness
Obstetrics/Gynecology
Orgasm
Pain
Pain Management
Physical therapy
Psychiatry
Psychotherapy
Psychotropic drugs
Serotonin
Somatoform disorders
Uterus
Vagina
Women
Singapore
genito-pelvic dysesthesia
bipolar disorder
gpd
brexpiprazole
persistent genital arousal disorder
pgad
Online AccessGet full text
ISSN2168-8184
2168-8184
DOI10.7759/cureus.50349

Cover

More Information
Summary:Although the symptoms of persistent genital arousal disorder/genito-pelvic dysesthesia (PGAD/GPD) can have negative impacts on patients' lives, it is an under-recognized clinical entity. We describe the case of a 61-year-old Japanese female who suffered simultaneously from bipolar disorder and PGAD/GPD. She developed PGAD/GPD approx. 10 years after being diagnosed with bipolar disorder. Despite 20 years of various drug treatments, her bipolar disorder and PGAD/GPD symptoms showed little improvement. She had also undergone multiple sessions of cognitive behavioral therapy (CBT) and mindfulness, nerve block, botulinum toxin injections, and laser treatment for PGAD/GPD. Her PGAD/GPD symptoms remained with no significant improvement, and her bipolar disorder symptoms had also not responded well to medication. With the administration of brexpiprazole, she achieved remission of her bipolar disorder. Her PGAD/GPD symptoms also eventually improved. When PGAD/GPD is comorbid with bipolar disorder, the improvement of bipolar disorder may also lead to relief of PGAD/GPD symptoms. This case reveals that brexpiprazole, which has a unique profile, may be effective for PGAD/GPD.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-4
ObjectType-Report-1
ObjectType-Article-3
content type line 23
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.50349